-5%
Naftol is used for the management of:
Benign prostatic obstruction (BPO)
Benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS)
Note: Naftol does not reduce prostate size.
Naftopidil is a selective α1-adrenergic receptor antagonist, showing higher affinity for α1D receptors. It works by:
Relaxing smooth muscles in the urethra and prostate, facilitating easier urination
Reducing the overactivity of the detrusor muscle